KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
-11.5%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$97.4M
AUM Growth
+$97.4M
(-14%)
Cap. Flow
-$801K
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
98.61%
Holding
13
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$741K |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$1.48M |
| 2 |
Soligenix
SNGX
|
$63K |
Sector Composition
| 1 | Healthcare | 99.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Abeona Therapeutics
ABEO
$350M
| $33.9M | 34.77% | 2,359,767 | – | – |
|
2
Corbus Pharmaceuticals
CRBP
$115M
| $23.5M | 24.16% | 3,856,985 | – | – |
|
|
BHVN
3
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $19.3M | 19.83% | 749,815 -57,409 | -7% | -$1.48M |
|
|
AMPE
4
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $8.83M | 9.06% | 2,595,484 | – | – |
|
5
Krystal Biotech
KRYS
$4.27B
| $3.03M | 3.11% | 300,000 | – | – |
|
|
NTBL
6
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $2.06M | 2.12% | 896,771 | – | – |
|
7
Anavex Life Sciences
AVXL
$828M
| $2M | 2.05% | 724,205 | – | – |
|
|
8
Soligenix
SNGX
$10.1M
| $1.64M | 1.68% | 837,800 -32,200 | -4% | -$63K |
|
9
Aldeyra Therapeutics
ALDX
$351M
| $931K | 0.96% | 124,096 | – | – |
|
10
VolitionRX
VNRX
$74.2M
| $844K | 0.87% | 351,538 | – | – |
|
|
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $741K | 0.76% | +75,238 | New | +$741K |
|
12
Evoke Pharma
EVOK
$8.49M
| $572K | 0.59% | 275,000 | – | – |
|
|
ADXSW
13
DELISTED
Advaxis, Inc. Warrants
ADXSW
| $45K | 0.05% | 112,500 | – | – |
|